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Summary. Malaria is an infectious disease that is caused by a group of parasites of the genus
Plasmodium. Characterizing the association between polymorphisms in the parasite genome
andmeasuredtraitsinaninfectedhumanhostmayprovideinsightintodiseaseaetiologyandul-
timately inform new strategies for improved treatment and prevention.This, however, presents
an analytic challenge since individuals are often multiply infected with a variable and unknown
number of genetically diverse parasitic strains.In addition, data on the alignment of nucleotides
on a single chromosome, which is commonly referred to as haplotypic phase, is not generally
observed. An expectation–maximization algorithm for estimating and testing associations
between haplotypes and quantitative traits has been described for diploid (human) populations.
We extend this method to account for both the uncertainty in haplotypic phase and the vari-
able and unknown number of infections in the malaria setting.Further extensions are described
for the human immunodeﬁciency virus quasi-species setting. A simulation study is presented
to characterize performance of the method. Application of this approach to data arising from a
cross-sectional study of nD126 multiply infected children in Uganda reveals some interesting
associations requiring further investigation.
Keywords: Expectation–maximization algorithm; Genotype; Haplotype; Human
immunodeﬁciency virus; Linear model; Malaria; Phenotype; Quasi-species; Strain
1. Introduction
Our investigation is motivated by a study of the human pathogenic species Plasmodium falci-
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parum, the group of parasites that cause malaria. Here, interest lies in characterizing associa-
tionsbetweengeneticpolymorphismsinthehaploidparasiteandclinicalmeasuresofseverityof
disease, such as red blood cell (RBC) count or the amount of parasite in plasma. In this setting,
multiple infections can arise as a result of two or more singly infected mosquitoes taking blood
meals from the same individual, an infected mosquito taking blood meals over several days or a
single multiply infected mosquito taking a blood meal from an individual. These three settings
are indistinguishable from a data analytic perspective and all result in multiple strains within
a single human host. In general, the observed genotype data consist of the set of nucleotides
at each location of the genome across the entire population of organisms within a single host.
Thus, as in the human genetics setting, the speciﬁc alignment of these nucleotides on a single
chromosome, which is called the haplotype, is generally unobservable. This constitutes the ﬁrst
analytic challenge.
The second challenge, rendering the infectious disease setting unique from human investiga-
tions, is that the number of infections is unknown and this number can vary across individuals.
Combined, these two challenges serve as the motivation for our present research. Consider, for
example, an individual who is infected by multiple parasites. Further suppose that the observed
genotype for this individual is Aa at one site and Bb at a second site on the genome, where
A, a, B and b are used to represent the observed nucleotide. In this simple case, there are four
possible haplotypes: h1 =.A,B/, h2 =.A,b/, h3 =.a,B/ and h4 =.a,b/. The precise combina-
tion of these haplotypes within this individual is not observable. In a human population, the
number of homologous chromosomes is ﬁxed at 2 and therefore the truth could be .h1,h4/
or .h2,h3/. However, in the malaria setting, since the number of strains within each person
is also unobserved, the number of copies of each haplotype is unknown. In this case, the true
haplotypecombinationcouldbe.h1,h4/,.h2,h3/,.h1,h4,h4/or.h1,h1,h4,h4/,etc.anddepends
on whether the individual has two, three or four infections. Note that two distinct strains may
have the same haplotype for the gene under consideration and thus we include, for example,
.h1,h4/ and .h1,h4,h4/ as two distinct possibilities.
Several methods for characterizing population level haplotype frequencies and haplotype–
trait associations in human populations have been described (Excofﬁer and Slatkin, 1995;
Stephensetal.,2001;Zaykinetal.,2002;StephensandDonnelly,2003;Schaidetal.,2002;Lake
et al., 2003; Lin and Zeng, 2006; Foulkes et al., 2008). In this paper, we propose an extension
of the EM approach for haplotype–trait association studies (Lake et al., 2003; Lin and Zeng,
2006)forinfectiousdiseasesettings.Hereinterestliessimilarlyincharacterizingtherelationship
between genetic information and a trait; however, in the infectious disease context, the genetic
information is typically measured on the infectious agent (such as a parasite or virus) rather
than the human. In both cases, we assume that the trait is a host (human) level measurement.
In previous work, we described an expectation–maximization (EM) type of algorithm for
estimating haplotype frequencies in the malaria setting that uses only the observed genotype
data (Li et al., 2007). This prior work, while extending the methods of Excofﬁer and Slatkin
(1995) and Hill and Babiker (1995), does not take into account phenotypic or clinical informa-
tion about the host. In this paper, we propose an EM-type algorithm that additionally takes
into account information on a measured trait. This provides a comprehensive framework for
simultaneous estimation of population haplotype frequencies and haplotype–trait associations.
Thus the method that is presented represents an extension of Li et al. (2007) to incorporate
trait information as well as an extension of Lake et al. (2003) and Lin and Zeng (2006) to the
non-diploid setting.
An underlying premise motivating our research is that haplotypes may explain variability in
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genetic settings, haplotype-based investigations are important if the polymorphisms under
consideration are in linkage disequilibrium with the true disease-causing variant but are not
themselves causal. In the malaria settings, the speciﬁc combinations of nucleotides on a single
strain may be relevant to protein production and, ultimately, to parasite ﬁtness. The method
that is presented herein provides the framework for evaluating these potential associations.
In Section 2, we describe an extension of the EM framework for estimation and inference
underseveralmodelsforthedistributionofthenumberofinfections.InSection3,thisapproach
isappliedinasimulationstudyaswellastodataarisingfromacohortofn=126multiplyinfected
children from Uganda. Section 4 describes extensions for the human immunodeﬁciency virus
(HIV) quasi-species setting in which multiple strains can arise from repeat infections though,
more generally, this is a result of external pressures, such as treatment exposures. Finally, in
Section 5 we provide a discussion of our ﬁndings.
2. Methods
Webegininthissectionbyoutliningournotationandthestructureofthedata.Wethendescribe
threeapproachestoestimationoftheeffectofhaplotypesonaquantitativetraitthateachinvolve
different assumptions about the distribution of the number of infections:
(a) we assume that the number of infections within a host is ﬁxed at a constant C>0;
(b) weassumethatthisnumberfollowsaconditionalPoissondistributionwherewecondition
on the presence of at least one infection;
(c) we make no assumption about the distribution of the number of infections and esti-
mate separately the probabilities of having exactly c infections where c=1,2,...,C for C
sufﬁciently large.
Finally, a formal testing procedure is described.
2.1. Notation
Let G=.G1,...,Gn/ where Gi is the unphased (observed) multisite genotype for individual
i. Further suppose that H=.H1,...,Hn/ where Hi represents the combination of haplotypes
within individual i. In general, Hi is not known and multiple values of Hi are consistent with
Gi. The set of all haplotype combinations that are consistent with Gi is denoted by S.Gi/.
Let h1,...,hK denote the K possible haplotypes over all observed individuals and deﬁne θ=
.θ1,...,θK/ where θk is the population frequency of hk. Now let Y=.Y1,...,Yn/ where Yi is the
trait for i=1,...,n. We model Y by using the generalized linear model such that the expected
value of Yi is related to the linear predictor .XT
i HT
i /β through a link function g:
g.E[Yi]/=.XT
i HT
i /β .1/
where Xi is a vector of environmental or demographic covariates, including the intercept as the
ﬁrst element, Hi is a vector of numerical codes for Hi and β is the corresponding parameter
vector.Foraquantitativetrait,g.·/reducestotheidentitylink.Sincethehaplotypecombination
for individual i is potentially unobserved, we consider all possible Hi that are consistent with
the observed genotype data, as described in Section 2.2. Hi can take many forms depending on
the speciﬁc genetic model. For example, we may deﬁne Hi as a K×1 vector of indicators for
the presence of a speciﬁc dominant haplotype in individual i. Alternatively, we can set the kth
element of Hi equal to the number of copies of hk in individual i, corresponding to an additive
genetic model. Further discussion of formulations for this design matrix are given in Lin and
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2.2. Estimation
In this section we describe the general EM framework for estimation, assuming a given
distribution for the number of infections. We then elaborate on this algorithm for each of
three distributional assumptions. First note that, for the generalized linear model framework,
we assume that the probability density of Y is from an exponential family, given by
Pr.Y|X,H,β/=L.β|Y,X,H/=
n  
i=1
exp
 
Yi.XT
i HT
i /β−b{.XT
i HT
i /β}
a.ψ/
+c.Yi,ψ/
 
.2/
where a, b and c are known functions, ψ is a scale parameter and in our setting H is unknown.
The ambiguity in H renders the haplotype-trait association study a missing data problem and
thus an EM-type algorithm is a natural choice for this setting. The EM algorithm, which was
formalized by Dempster et al. (1977), involves ﬁrst taking the conditional expectation of the
complete-datalog-likelihood(E-step),maximizingthiswithrespecttotheparametersofinterest
(M-step) and then iterating between these two steps until a convergence criterion has been met.
In our setting, the observed data consist of Y, X and G and are denoted X.obs/, whereas the
complete data consist of Y, X, G and H and are denoted X.com/. Let Φ be the parameters of
interest, as described in each of the following sections. The complete-data likelihood for Φ is
thus given by
L.Φ|X.com//=
n  
i=1
Pr.Yi|Xi,Hi,β/Pr.Hi|θ/. 3/
where Pr.Hi|θ/ is the corresponding haplotype set probabilities for the ith individual. Notably,
this likelihood assumes that the haplotype frequencies are independent of environmental or
demographicinformation.Ingeneral,ifdeparturesfromthisassumptionaretenable,astratiﬁed
analysis may be appropriate. As seen below, Pr.Hi|θ/ depends on the particular assumptions
that are made with respect to the number of infections.
Let ˆ Φ
.t/
be the estimate of Φ derived from the tth iteration of the EM algorithm. Formally,
we have that the expectation of the complete-data log-likelihood conditional on the observed
data and the current parameter estimates is given by
E[log{L.Φ|X.com//}|X.obs/, ˆ Φ
.t/
]=
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/[log{Pr.Yi|Xi,Hi,β/}+log{Pr.Hi|θ/}]
.4/
where
piHi. ˆ Φ
.t/
/=p{Hi|Hi∈S.Gi/,Yi,Xi, ˆ Φ
.t/
}=
Pr.Yi|Xi,Hi, ˆ β
.t/
/Pr.Hi| ˆ θ
.t/
/
 
Hi∈S.Gi/
Pr.Yi|Xi,Hi, ˆ β
.t/
/Pr.Hi| ˆ θ
.t/
/
:. 5/
Next, we maximize the conditional expectation of the complete-data log-likelihood given in
equation (4). It is straightforward to show that the (t+1)th estimate of Φ can be obtained by
ﬁnding the root for the equations
@E[log{L.Φ|X.com//}|X.obs/, ˆ Φ
.t/
]
@β
=
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/
@log{L.β|Yi,Xi,Hi/}
@β
=
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/
.Yi−E[Yi|Xi,Hi,β]/.XT
i HT
i /T
a.ψ/
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and
@E[log{L.Φ|X.com//}|X.obs/, ˆ Φ
.t/
]
@θk
=
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/
@log{Pr.Hi|θ/}
@θk
=0:. 7/
As noted in Lake et al. (2003) for the diploid setting, equation (6) reveals that the regression
parameter β can be estimated via weighted regression, where the weights are the posterior
probabilities of the haplotype sets for each individual, allowing us to use standard statistical
software packages at this step. In the following subsections we describe estimation under
speciﬁc assumptions for Pr.Hi|θ/. We assume convergence of the algorithm when max.| ˆ Φ
.t/
−
ˆ Φ
.t+1/
|= ˆ Φ
.t/
/<1:0×10−5. Alternatively, a convergence criterion can be based on the observed
data likelihood, which is given by
n  
i=1
 
Hi∈S.Gi/
Pr.Yi|Xi,Hi,β/Pr.Hi|θ/:
2.2.1. Fixed number of infections
Let δik denote the number of copies of haplotype hk in the haplotype combination Hi. First
suppose that there are exactly C strains in each individual where C>0, i.e. assume that each
individual has exactly C infections, where C is some known positive integer. This implies that
ΣK
k=1δik =C, where δik ranges from 1 to C.P r .Hi|θ/ of equation (3) is thus given by
Pr.Hi|θ/=
C!
δi1!...δiK!
K  
k=1
θ
δik
k :. 8/
In this case, Φ=.β,θ/. Plugging equation (8) into equation (7), we have
@E[log{L.Φ|X.com//}|X.obs/, ˆ Φ
.t/
]
@θk
=
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/
 
δik
θk
−
δiK
θK
 
=0:. 9/
Resulting closed form solutions for ˆ θk (see Appendix A.1) are given by
ˆ θ
.t+1/
k =
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/δik
nC
:. 10/
2.2.2. Poisson assumption on the numbers of infections
InSection2.2.1weassumedthatthenumberofinfectionsisﬁxed;however,ingeneralthisnum-
ber may be variable for each individual. In this section we relax this assumption and instead
assume a Poisson distribution on the number of infections per individual, as described in Hill
and Babiker (1995). Since data sets are generally comprised only of individuals with at least
one detectable infection, the conditional Poisson model is considered. Let the Poisson model
conditioning on at least one infection be given by
φc.λ/=
  λc=c!
exp.λ/−1
c>0,
0 c=0
.11/
whereφc.λ/istheprobabilityofhavingc infections.Inthiscase,Φ=.β,θ,λ/.Sincethenumber
ofstrainsci canbedeterminedfromHi,equation(8)forthehaplotypecombinationprobabilities
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Pr.Hi|θ,λ/=Pr.Hi,ci|θ,λ/=φci.λ/
ci!
δi1!...δiK!
K  
k=1
θ
δik
k .12/
where ci is the number of infections for the ith individual. Estimation of θ proceeds similarly to
the setting in which C is ﬁxed. Straightforward calculation (see Appendix A.2) leads to closed
form solutions for ˆ θk given by
ˆ θ
.t+1/
k =
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/δik
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/ci
:. 13/
Estimation of λ is achieved by solving
@E[log{L.Φ|X.com//}|X.obs/, ˆ Φ
.t/
]
@λ
=
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/
@log{Pr.Hi|θ,λ/}
@λ
=
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/
 
ci
λ
−
exp.λ/
exp.λ/−1
 
=0:. 14/
There is no closed form for ˆ λ and a Newton–Raphson procedure can be employed. In this set-
ting,thenumberofpossiblestrainsinanindividualisnotlimited,whichleadstoaninﬁnitesum
in the E-step of the EM algorithm. In practice, we consider the number of strains to be limited
by a large number (C) such that the probability of having more than C infections is small.
2.2.3. Semiparametric approach
Finally, we consider the approach in which no assumptions are made about the distribution of
the number of infections. In this approach, we estimate separately the probabilities of having
exactly c infections where c=1,2,...,C for C sufﬁciently large. Let qc be the probability of
having c infections and deﬁne q=.q1,...,qC/ and Φ=.β,θ,q/. Equation (8) for the haplotype
set probabilities is now replaced by
Pr.Hi|θ,q/=
ci!
δi1!...δiK!
K  
k=1
θ
δik
k
C  
c=1
qI.ci=c/
c .15/
where I.ci=c/ equals 1 if ci=c and 0 otherwise. Estimation of q proceeds by solving
@E[log{L.Φ|X.com//}|X.obs/, ˆ Φ
.t/
]
@qc
=
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/
@log{Pr.Hi|θ,q/}
@qc
=
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/
 
I.ci=c/
qc
−
I.ci=C/
qC
 
=0 .16/
and resulting closed form solutions (see Appendix A.3) for ˆ qc a r eg i v e nb y
ˆ q.t+1/
c =
1
n
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/I.ci=c/: .17/
2.3. Inference
Waldtestsareusedtotesthypothesesofhaplotype–traitassociations.Todothis,estimatesofthe
model parameters and the corresponding variance–covariance matrix are needed. EstimationHaplotype–Trait Associations in Non-diploid Populations 669
of the variance–covariance matrix proceeds by inverting the observed information matrix,
which is computed via Louis’s method within the EM framework (Louis, 1982). An alternative
approach is to approximate the observed information matrix with the empirical observed infor-
mation matrix which can be computed by (Meilijson, 1989)
Ie.Φ;X/=
n  
i=1
si.Φ/sT
i .Φ/|Φ= ˆ Φ .18/
where ˆ Φ is the estimate of the parameters in the last EM iteration and si.Φ/ is the score function
from the observed data likelihood for the ith individual. The score is given by (McLachlan and
Krishnan, 1997)
si.Φ/=EΦ
 
@log{Li.Φ|X
.com/
i /}
@Φ
 
 
 
 X
.obs/
i , ˆ Φ
 
:. 19/
For example, under the ﬁxed number of infections assumption, we have
si.Φ/=
 
Hi∈S.Gi/
piHi. ˆ Φ/
⎛
⎜
⎜
⎝
.Yi−E[Yi|Xi,Hi,β]/.XT
i HT
i /T=a.ψ/
δi1=θ1−δiK=θK
: : :
δik−1=θk−1−δiK=θK
⎞
⎟
⎟
⎠:. 20/
3. Data examples
In the following simulation study and real data example we focus on a quantitative trait for ease
of presentation. In this case, g.·/ of equation (1) is set equal to the identity link and we have the
linear regression model
Yi=.XT
i HT
i /β+"i:. 21/
We further assume the "i are independent and normally distributed with mean 0 and variance
given by σ2.Notably,thismodelassumeshomoscedasticityandisthereforeapplicablewhenthe
standard deviation of the trait is constant over the values of X and H. In the real data example
that is provided below, we have no biological reason to believe that there is a violation of
this assumption though, in general, evaluation of the appropriateness of the homoscedasticity
assumption can be achieved through close examination of residual plots.
3.1. Simulation study
To evaluate the performance of the methods that were described in Section 2, we conduct a
simulation study and report the type 1 error rates (ERs) and power under each of the three
models for the number of infections: ﬁxed, Poisson and semiparametic. The simulation starts
by generating the number of infections c for each individual. Under the ﬁxed number model,
the number of infections is set equal to a constant C. Under the Poisson assumption, c is gener-
ated randomly from a conditional Poisson distribution with assumed rate parameters λ=2 and
λ=3. Finally, under the semiparametric approach, we assume that the number of infections c
ranges from 1 to 4 with corresponding probabilities q=.0:3,0:3,0:2,0:2/.
Next we simulate the haplotype combination for each individual on the basis of the
multinomial distribution. Four haplotypes, which are given by h1 =.A1,B1/, h2 =.A1,B2/,
h3 =.A2,B1/ and h4 =.A2,B2/, with corresponding population frequencies of θ=.0:25,0:35,
0:20,0:20/, are assumed. The trait Y is generated by using random sampling with the error670 X. Li, B. N.Thomas, S. M. Rich, D. Ecker, J. K.Tumwine and A. S. Foulkes
generated from a normal distribution. A single haplotype effect is assumed with an effect size
ranging from 0.2 to 0.8. For simplicity of presentation, we let σ2=1 and vary β. In addition, we
consider a model in which there is no haplotype effect, in which case the response is generated
simply from a normal distribution with mean and variance equal to 1. In all cases, a dominant
geneticmodelisassumed.Foreachconﬁguration,B=200datasetswithsamplesizesofn=500
are generated. Analysis is performed using genotype data and trait information only, i.e. we
assume that the haplotypic phase and the number of infections are unknown and apply the
methods that were described in Section 2.
Simulation results are provided in Table 1. Bias, coverage rates, power and ER are reported.
Bias is deﬁned as the absolute difference between the mean parameter estimates over the
simulations and the true value. The estimated standard error of the parameter estimates based
on the simulations is given by   se. The parameter β1, the haplotype effect for the ﬁrst haplotype
h1=.A1,B1/, is varied across the simulations. Power is deﬁned as the proportion of simulations
in which we detect the true haplotype effect. The ER is the proportion of simulations for which
an incorrect haplotype is detected, averaged over the haplotypes that are assumed to have no
effect.
Under each of the three model assumptions and a range of haplotype effect sizes, the bias
ranges from less than 0.001 to 0.086 and the coverage rates are between 0.92 and 0.97. This
suggeststhatouralgorithmresultsinreasonablywell-calibratedintervalestimates.Asexpected,
the power for detecting the haplotype effect increases as the effect size increases from 0.0 to 0.8.
In general, for samples of size of n=500, we achieve greater than 80% power to detect moderate
effect sizes of greater than 0.40. Notably, however, we see a reduction in power and an increase
in the bias for β1 as the number of infections (parasite strains) is increased from 2 to 4 under
the ﬁxed number assumption. This is likely to be the result of increased ambiguity associated
with more possible haplotype combinations within an individual as the number of infections
(C) increases.
To evaluate the performance of the proposed method when the number of infections violates
model assumptions, we conduct several sensitivity analyses. First, we perform estimation by
using the ﬁxed approach, assuming that the number of infections is equal to 2, when in fact
the probabilities of having c infections for c =1,...,5 are all equal to 0.2. The results are
presented in Table 2, part (a). Comparing this with correct application of the semiparametric
method (Table 1), we see a dramatic loss of power and a less severe, but noteworthy, decrease
in coverage rates for both β and θ. In addition, the type 1 ER is substantially larger for β10:4.
Secondly, we perform estimation by using the ﬁxed number approach, again assuming that
the number of infections is equal to 2, when in fact the number of infections arises from a
conditional Poisson distribution with λ=2. The results are presented in Table 2, part (b).
Comparing these results with correct application of the Poisson approach with λ=2 (Table 1),
we see a more dramatic decrease in coverage rates for both β and θ. In addition, a signiﬁcant
decreaseinpowerandincreaseinthetype1ERareobservedforβ0:2.Theseﬁndingssupport
the use of the more sophisticated modelling approaches in these settings.
Next, we perform estimation by using the Poisson approach when in fact the probabilities
of having c infections for c=1,...,5areallequal to 0.2 and we present the results in Table 2,
part (c). Here the modelling approach provides estimates of λ and, from this, we calculate ˆ qc
as . ˆ λ
c
=c!/={exp. ˆ λ/−1}. As expected under this type of model misspeciﬁcation, the coverage
rates for qc are very low (0.12–0.15). Interestingly, the coverage rates for both β and θ remain
at approximately 95% and the power and ER are reasonable, though slightly worse than using
the correct model (Table 1). Finally, we evaluate performance in applying the semiparametric
approach when the number of infections actually arises from a Poisson distribution with λ=2.Haplotype–Trait Associations in Non-diploid Populations 671
Table 1. Simulation results for the dominant model under three assumptions†
β1‡ Bias ( se)§ Coverage rates§§ PowerÅ ERÅÅ
ˆ β1 ˆ λ ¯ ˆ θ β1 λ ¯ θ
Fixed number model
C = 2 0.0 0.0038 (0.132) — 0.0008 (0.016) 0.95 — 0.95 0.05 0.06
0.2 0.0009 (0.138) — 0.0005 (0.015) 0.96 — 0.95 0.35 0.07
0.4 0.0060 (0.138) — 0.0013 (0.015) 0.96 — 0.95 0.82 0.06
0.6 0.0002 (0.126) — 0.0003 (0.016) 0.95 — 0.95 0.99 0.06
0.8 0.0016 (0.122) — 0.0008 (0.015) 0.94 — 0.95 1.00 0.05
C = 3 0.0 0.0035 (0.180) — 0.0007 (0.018) 0.94 — 0.94 0.08 0.07
0.2 0.0122 (0.181) — 0.0009 (0.017) 0.95 — 0.95 0.22 0.08
0.4 0.0136 (0.187) — 0.0006 (0.017) 0.95 — 0.95 0.59 0.08
0.6 0.0265 (0.181) — 0.0011 (0.017) 0.95 — 0.95 0.88 0.08
0.8 0.0291 (0.177) — 0.0004 (0.017) 0.95 — 0.94 0.97 0.07
C = 4 0.0 0.0128 (0.206) — 0.0066 (0.019) 0.94 — 0.92 0.07 0.06
0.2 0.0078 (0.223) — 0.0037 (0.019) 0.97 — 0.94 0.20 0.09
0.4 0.0443 (0.212) — 0.0065 (0.020) 0.96 — 0.94 0.38 0.06
0.6 0.0856 (0.185) — 0.0048 (0.020) 0.93 — 0.95 0.62 0.07
0.8 0.0627 (0.197) — 0.0046 (0.018) 0.92 — 0.95 0.88 0.06
Poisson model
λ=2 0.0 0.0098 (0.126) 0.0022 (0.111) 0.0025 (0.020) 0.96 0.94 0.94 0.04 0.05
0.2 0.0011 (0.150) 0.0093 (0.105) 0.0011 (0.019) 0.95 0.95 0.95 0.41 0.05
0.4 0.0001 (0.128) 0.0101 (0.089) 0.0013 (0.020) 0.96 0.96 0.97 0.87 0.06
0.6 0.0240 (0.129) 0.0042 (0.116) 0.0018 (0.020) 0.94 0.98 0.96 1.00 0.03
0.8 0.0160 (0.146) 0.0091 (0.104) 0.0012 (0.019) 0.96 0.95 0.94 0.99 0.05
λ=3 0.0 0.0022 (0.131) 0.0087 (0.123) 0.0017 (0.019) 0.96 0.97 0.94 0.04 0.03
0.2 0.0312 (0.129) 0.0372 (0.124) 0.0027 (0.019) 0.95 0.96 0.95 0.44 0.04
0.4 0.0002 (0.122) 0.0043 (0.137) 0.0017 (0.020) 0.94 0.96 0.95 0.91 0.05
0.4 0.0055 (0.129) 0.0216 (0.137) 0.0009 (0.018) 0.93 0.96 0.94 0.99 0.06
0.8 0.0120 (0.116) 0.0067 (0.126) 0.0024 (0.020) 0.97 0.96 0.94 1.00 0.06
¯ ˆ q ¯ q
Semi-parametric model
0.0 0.0034 (0.117) 0.0112 (0.033) 0.0024 (0.019) 0.95 0.79 0.96 0.05 0.03
0.2 0.0082 (0.108) 0.0119 (0.030) 0.0027 (0.018) 0.94 0.85 0.95 0.38 0.06
0.4 0.0024 (0.118) 0.0119 (0.029) 0.0018 (0.018) 0.96 0.81 0.96 0.94 0.06
0.6 0.0321 (0.141) 0.0132 (0.032) 0.0027 (0.019) 0.97 0.83 0.96 1.00 0.04
0.8 0.0015 (0.116) 0.0119 (0.032) 0.0007 (0.018) 0.96 0.83 0.95 1.00 0.05
† ¯ ˆ θ and ¯ ˆ q denote averaging across all ˆ θs and ˆ qs respectively. ¯ θ and ¯ q denote averaging across all θs and qs respec-
tively.
‡β1 is the effect of haplotype h1=.A1,B1/ on Y.
§Bias is deﬁned as the absolute difference between the mean of the estimate over the simulations and the true
parameter value.
§§Coverage rate is deﬁned as the proportion of simulations for which the true parameter value is within the cor-
responding 95% conﬁdence interval.
ÅPower is the speciﬁc power for the haplotype effect of the ﬁrst haplotype h1.
ÅÅER is the type 1 error rate.
These results are given in Table 2, part (d), and, as expected, we see a slight loss of power for the
smallereffectsizes.Forexample,foraneffectsizeof0.4,thepowerofcorrectlyusingthePoisson
approach is 0.87 (Table 1). Power for the semiparametric approach is estimated to be 0.81. Since
we are not incorporating knowledge about the distribution of the number of infections the loss
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Table 2. Sensitivity analysis to model misspeciﬁcation
βÅ
1 Bias Coverage rates Power ER
ˆ β1 ¯ ˆ q ¯ ˆ θ β1 ¯ q ¯ θ
(a) Incorrect application of the ﬁxed approach under semiparametric data†
0.0 0.0016 (0.133) 0.0332 (0.044) 0.95 0.90 0.03 0.04
0.2 0.0441 (0.165) 0.0334 (0.045) 0.93 0.92 0.22 0.04
0.4 0.0810 (0.187) 0.0366 (0.042) 0.92 0.86 0.59 0.12
0.6 0.0761 (0.251) 0.0303 (0.041) 0.92 0.88 0.88 0.22
0.8 0.1081 (0.329) 0.0214 (0.044) 0.93 0.93 0.95 0.30
(b) Incorrect application of the ﬁxed approach under Poisson-distributed data‡
0.0 0.0158 (0.178) 0.0640 (0.104) 0.93 0.99 0.08 0.07
0.2 0.1112 (0.175) 0.0850 (0.083) 0.89 0.92 0.13 0.09
0.4 0.1499 (0.187) 0.0985 (0.065) 0.91 0.64 0.30 0.16
0.6 0.2177 (0.219) 0.0972 (0.068) 0.86 0.68 0.65 0.25
0.8 0.3546 (0.353) 0.0722 (0.092) 0.87 0.98 0.83 0.40
(c) Incorrect application of the conditional Poisson model§
0.0 0.0086 (0.115) 0.0492 (0.009) 0.0023 (0.022) 0.97 0.15 0.95 0.02 0.04
0.2 0.0110 (0.142) 0.0491 (0.009) 0.0019 (0.022) 0.95 0.14 0.95 0.37 0.07
0.4 0.0026 (0.129) 0.0489 (0.008) 0.0011 (0.020) 0.96 0.12 0.94 0.90 0.05
0.6 0.0039 (0.141) 0.0492 (0.008) 0.0010 (0.021) 0.94 0.13 0.96 0.99 0.05
0.8 0.0134 (0.102) 0.0492 (0.009) 0.0010 (0.020) 0.95 0.15 0.94 1.00 0.06
(d) Incorrect application of the semiparametric approach under Poisson-distributed data§§
0.0 0.0113 (0.114) 0.0027 (0.019) 0.96 0.95 0.04 0.05
0.2 0.0166 (0.123) 0.0025 (0.021) 0.95 0.95 0.34 0.04
0.4 0.0316 (0.147) 0.0025 (0.020) 0.97 0.96 0.81 0.04
0.6 0.0191 (0.115) 0.0022 (0.021) 0.95 0.95 1.00 0.05
0.8 0.0233 (0.121) 0.0010 (0.019) 0.94 0.94 1.00 0.04
†The data are simulated assuming between one and ﬁve infections with equal probabilities of 0.20
whereas the estimation approach assumes c=2 ﬁxed infections. See the caption for Fig. 1 for deﬁ-
nitions of terms.
‡The data are simulated assuming a conditional Poisson distribution with λ=2, whereas the esti-
mation procedure assumes c=2 ﬁxed infections.
§The data are simulated assuming between one and ﬁve infections with equal probabilities of 0.20.
§§The data are simulated assuming a conditional Poisson distribution with λ=2. The number of
infections is assumed to range from 1 to 10.
3.2. Multiply infected children with malaria
Malaria is an infectious disease affecting millions of individuals globally. In fact, each year an
estimated (1–3)-million people die as a result of infection with the human pathogenic Plasmo-
dium species, the group of parasites that causes malaria (Breman, 2001). The majority of these
deathsareinchildrenundertheageof5yearsandinresource-constrainedsettingssincecurrent
treatmentoptionsarecostlyorunavailable(Greenwoodetal.,2005;Guerraetal.,2008).Recent
advances in sequencing technologies provide new opportunities for population-based genetic
association studies to uncover complex relationships between genetic polymorphisms and
measures of progression of disease. Ultimately, these discoveries may help to inform novel
strategies for vaccine development.
One of the biggest challenges in characterizing genotype–trait associations in this setting
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strains. In the present investigation, we apply an EM approach (see Section 2) to data arising
from a cross-sectional study of n = 126 malaria-infected children from Uganda. We focus
on haplotypes in one polymorphic circumsporozoite protein (CSP) region (CSP-TH3) of the
gene that encodes for a cellular adhesion domain of the CSP. The CSP facilitates adhesion
of the parasite to liver cells, which is a critical initial step in its replication process in a hu-
man host (Zavala et al., 1983; Hollingdale et al., 1984). The goal of our analysis is to uncover
haplotype associations with RBC count (log-transformed). The RBC count is a well-known
diagnostic tool for detecting anaemia, which is a common and often lethal manifestation of
malaria.
Dataon12sites,10ofwhicharepolymorphicinoursample,areconsidered.Notably,sitesthat
areconstantacrossourdatadonotinformtheanalysisbutareincludedforcompleteness.Across
all individuals, we see up to three different nucleotides at a site and, within a single individual,
one or two nucleotides are present at any given site. A total of 35 unique genotypes are observed
in our data and a sample of the data is provided in Li et al. (2007). For computational purposes,
the set of possible haplotypes is limited to those with estimated frequencies of greater than 0.01
where frequency estimates are obtained by using the approach of Li et al. (2007). We assume
a Poisson distribution and apply the approach of Section 2.2.2. A dominant genetic model is
assumed, as in the simulation study.
Estimated haplotype effects on the RBC and corresponding p-values for tests of the null
hypothesesthattheseeffectsequal0areprovidedinTable3.Thep-valuesareunadjustedformul-
tiple comparisons. Using a Bonferroni adjustment, p-values that are less than 0.05/14=0.0036
are considered signiﬁcant at the 0.05-level. A signiﬁcant association is observed between the
RBCcountandthethreehaplotypesnumbered8,11and12.Interestingly,theeffectofcarrying
atleastonecopyofhaplotype11appearstoincreasetheRBCcountexp.0:344/=1:41-fold,sug-
gestingapotentialprotectiveeffect.Incontrast,haplotypes8and12resultinalowerRBCcount
withestimateddecreasesofexp.−0:484/=0:616-foldandexp.−0:137/=0:872-foldrespectively.
Table 3. Estimated haplotype effects for Uganda†
Unique haplotype Estimated Estimated Standard p-value
frequency ˆ θ effect ( ˆ β) error
1 TGAACGCCGAGC 0.328 −0.108 0.099 0.278
2 TGAACGCCGAGA 0.241 −0.066 0.092 0.471
3 TGAACGCGAAGA 0.103 −0.032 0.106 0.762
4 TGAACGCGGAGA 0.057 −0.148 0.150 0.324
5 TGGGTACGGAGA 0.044 −0.257 0.151 0.089
6 TGGGCGCGGAGC 0.046 −0.081 0.240 0.737
7 TGAACGCCAAGA 0.046 −0.023 0.165 0.891
8 TGGACGCCGAGC 0.041 −0.484 0.133 <0.001‡
9 TGAACGCGGAGC 0.034 0.200 0.583 0.731
1 0 TGGGCACGGAGA 0.022 0.159 0.331 0.631
1 1 TGGGTGCGGAGA 0.011 0.344 0.008 <0.001‡
1 2 TGGACGCCGAAT 0.005 −0.137 0.000 <0.001‡
1 3 TGGGCGAGAAGA 0.011 0.292 0.806 0.717
1 4 TGGACGCCGAGA 0.009 0.206 2.031 0.919
†The results are based on a sample of size n=126 and assume a Poisson model for the
number of strains per individual.
‡The haplotype effect on the RBC count is signiﬁcantly different from 0 after applying a
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Notably, the estimated number of individuals with each of these haplotypes (which is given by
126ˆ θk) is small and further conﬁrmatory research is required to make ﬁrm conclusions.
4. Further extensions for the quasi-species setting
In the methods that were described above for estimation of haplotype effects on a trait, we
incorporate population level haplotype frequencies. These frequencies can be thought of as the
amount of each parasite strain circulating in the mosquito population that infects humans.
Importantly, we assume that the frequencies within individuals reﬂect these population level
parameters.Inotherwords,theprobabilityofbeinginfectedwithagivenstraindoesnotdepend
on prior infections and is equal to the proportion of this strain in the general population.
Patients who are infected with HIV similarly host a population of viruses; however, the pres-
ence of such a quasi-species generally results from external pressures, such as drug exposures,
rather than multiple repeat infections. As a result, the frequencies of each haplotype within an
individual may not reﬂect the true population level frequencies. This is evidenced, for example,
by the existence of latent reservoirs of resistant variants that rapidly emerge in the presence of
a drug.
For this reason, rather than using population level haplotype frequencies in the HIV setting,
we consider the probabilities that an individual in the target population carries a given haplo-
type.Althoughthisdistinctionissubtle,itdoesrequiremodiﬁcationoftheestimationapproach
that was described in Section 2. Again let Gi be the unphased (observed) multisite genotype
for the ith individual where i=1,...,n. Further suppose that Hi represents the combination
of unique haplotypes within individual i where Hi is generally unobservable and multiple val-
ues of Hi are consistent with Gi. We emphasize unique here since, in the previously described
approach,suchaminimalsetwasnotrequired,i.e.wearenowinterestedinwhetheranindividual
carries a speciﬁc haplotype and not in the number of copies. Again, the set of all combinations
that are consistent with Gi is denoted S.Gi/ and h1,...,hK denotes the K possible haplotypes
overallobservedindividuals.Letα=.α1,...,αK/whereαk istheprobabilitythatanindividual
carries at least one copy of hk and deﬁne
δik =
 
1i f hk is present in the ith individual,
0i f hk is not present in the ith individual.
.22/
Under the model that is given in equation (1), the complete likelihood function can again be
written as in equation (3) where Pr.Hi|θ/ is replaced with
Pr.Hi|α/=
K  
k=1
α
δik
k .1−αk/1−δik:. 23/
In this case, estimation of the regression parameter β proceeds as described above and an esti-
mate of α is obtained by ﬁnding the root of the equation
@E[log{L.Φ/|X.com/}|X.obs/, ˆ Φ
.t/
]
@αk
=
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/
@log{Pr.Hi|α/}
@αk
=
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/
 
δik
αk
−
1−δik
1−αk
 
=0:. 24/
Resulting closed form solutions (see Appendix A.4) for ˆ αk a r eg i v e nb yHaplotype–Trait Associations in Non-diploid Populations 675
ˆ α
.t+1/
k =
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/δik
n
:. 25/
5. Discussion
Inthispaper,wedescribeanapproachtoestimateandtesthaplotype–traitassociationsbetween
individuals with multiple strains of an infectious agent. Three approaches to modelling the
number of infections were described in Section 2. The ﬁrst, which involves ﬁxing the number of
infections to be a constant C, is presented since it represents a natural extension of the diploid
setting, within which C=2 and our approach reduces to the EM method of Lake et al. (2003).
Since in the infectious disease setting the number of infections is rarely known with certainty,
this ﬁrst approach may be more relevant to investigations of polyploidy organisms in which the
numberofhomologouschromosomesisgreaterthan2,suchasﬂatworms,goldﬁsh,salmonand
a variety of ferns and ﬂowering plants. Note that the assumption of independent segregation
that is made in equation (8) needs to be addressed speciﬁcally for each of these settings.
Our simulation study suggests that application of the Poisson approach, when in fact the
numbers of infections are c=1,...,5with equal probabilities, results in reasonable power and
type 1 ERs but substantial bias in these probability estimates. The semiparametric approach
performs reasonably well under the Poisson model with a slight loss of power. Incorrect
application of the ﬁxed number approach leads to more substantial losses of power, reductions
in coverage rates and increases in type 1 ERs. Applications of the correct models lead to
reasonable power and control of type 1 ERs.
Coupled with this investigation is the need for appropriate methods for controlling type 1
ERs in the context of multiple comparisons. In Section 3.2, we applied a Bonferroni correction
toassesssigniﬁcance.Alternativesingle-stepandstep-downmethodsthatarebasedonthefalse
discoveryrateandthataccountforthecorrelatednatureofthesetests(BenjaminiandHochberg,
1995; Benjamini and Yekutieli, 2001; Storey and Tibshirani, 2003) are also tenable. In addition,
further consideration of resampling-based approaches and related extensions (Westfall and
Young, 1993; Pollard and van der Laan, 2004; Foulkes and DeGruttola, 2007) may be appro-
priate. Extensions of the mixed effects modelling approaches that were developed originally for
the diploid setting (Foulkes et al., 2007, 2008) would offer a single degree of freedom omnibus
test for association across all haplotypes.
Notably, our analysis is limited to data arising from individuals who visited one of the
designated clinics. This may lead to ascertainment bias for several reasons, including that the
individuals under study exhibited symptoms that were sufﬁciently severe to warrant at least
one visit to the doctor. This is a potential limitation of the method that is described herein.
Speciﬁcally, a population level prevalence greater than 0 of infection by a strain that results in
mild symptoms may result in overestimation of the frequencies of haplotypes that lead to more
severe symptoms.
Application of this EM approach to a small cohort of children in Uganda revealed three
potentially informative haplotypes within the CSP region of the parasite genome. In general,
characterizing the association between polymorphisms in the parasite genome and measured
traits in an infected human host may provide greater insight into disease aetiology and help
to inform new strategies for treatment and vaccine development efforts. Drawing meaningful
biological and clinical conclusions, however, will require further analysis. Speciﬁcally consid-
eration of host level factors, such as host genetic proﬁle and clinical or demographic features,
may be warrented. The methods that are described herein provide a general framework and the676 X. Li, B. N.Thomas, S. M. Rich, D. Ecker, J. K.Tumwine and A. S. Foulkes
analytic tools to investigate such associations under several models of association and models
for the numbers of infections.
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Appendix A
A.1. Estimation under ﬁxed number of infections
Note that the sum of the population level haplotype frequencies must equal 1, so we have θK =1−Σ
K−1
k=1 θk.
Equation (9) is then given by
@E[log{L.Φ|X.com//}|X.obs/, ˆ Φ
.t/
]
@θk
=
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/
⎛
⎝δik
θk
−
δiK
1−
K−1  
k=1
θk
⎞
⎠=0
for k=1,...,K−1 or, equivalently,
⎛
⎜
⎜
⎜
⎜
⎜
⎜
⎜
⎜
⎜
⎝
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/δi1=θ1
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/δi2=θ2
: : :
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
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⎟
⎟
⎟
⎟
⎟
⎟
⎟
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⎜
⎜
⎜
⎜
⎜
⎜
⎝
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/δiK
 
 
1−
K−1  
k=1
θk
 
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/δiK
 
 
1−
K−1  
k=1
θk
 
: : :
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/δiK
 
 
1−
K−1  
k=1
θk
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⎟
⎟
⎟
⎟
⎟
⎟
⎟
⎟
⎟
⎟
⎟
⎠
:. 26/
Note that all the elements of the vector on the right-hand side of equation (26) are equal. Therefore, we
can set the ﬁrst element of the vector on the left-hand side of equation (26) equal to each of the remaining
elements of this vector, which yields
θk =
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/δik
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/δi1
θ1:. 27/
Thus we can derive an estimate of θ1 and use equation (27) to ﬁnd estimates of θk for k=2,...,K−1.
From the ﬁrst element of equation (26) we have
θ1
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/δiK =
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/δi1
⎧
⎪ ⎪ ⎨
⎪ ⎪ ⎩
1−θ1−θ1
K−1  
k=2
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/δik
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/δi1
⎫
⎪ ⎪ ⎬
⎪ ⎪ ⎭
=
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/δi1−θ1
K−1  
k=1
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
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or equivalently
θ1
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/
K  
k=1
δik =
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/δi1:. 28/
Finally, since ΣK
k=1δik =C and ΣHi∈S.Gi/piHi =1, equation (28) yields
ˆ θ
.t+1/
1 =
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/δi1
nC
:
A.2. Estimation under Poisson assumption
Under the Poisson assumption, we have ΣK
k=1δik =ci and therefore equation (28) is written
θ1
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/ci=
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/δi1
resulting in
ˆ θ
.t+1/
1 =
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/δi1
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/ci
:
A.3. Estimation for semiparametric approach
Note that the sum of the qc must equal 1, so we have qC =1−Σ
C−1
c=1 qc and equation (16) is given by
@E[log{L.Φ|X.com//}|X.obs/, ˆ Φ
.t/
]
@qc
=
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/
 
I.ci=c/
qc
−
I.ci=C/
1−
C  
c=1
qc
 
=0
for c=1,...,C−1. Using the same approach as described in Appendix A.1, we have
ˆ q
.t+1/
c =
1
n
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/I.c i=c/: .29/
A.4. Estimation for quasi-species setting
From equation (24), we have
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/δik
αk
=
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/.1−δik/
1−αk
or equivalently
αk
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/=
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/δik:. 30/
Since Σn
i=1ΣHi∈S.Gi/piHi. ˆ Φ
.t/
/=n, equation (30) yields
ˆ α
.t+1/
k =
n  
i=1
 
Hi∈S.Gi/
piHi. ˆ Φ
.t/
/δik
n
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